Effect of rosuvastatin on sortilin and fetuin-A in type 2 diabetic patients: a randomized controlled trial
Sign Up to like & getrecommendations! Published in 2024 at "International Journal of Diabetes in Developing Countries"
DOI: 10.1007/s13410-024-01324-6
Abstract: Rosuvastatin is a drug used for decreasing the risk of cardiovascular complications in type 2 diabetes mellitus (T2DM) patients. It is hypothesized that fetuin-A encourages lipid-induced insulin resistance and sortilin may increase the risk of… read more here.
Keywords: sortilin fetuin; placebo; rosuvastatin; t2dm patients ... See more keywords